CD8+ cytotoxic T lymphocytes (CTLs) are considered the main executors of adaptive immunity, as they eliminate tumor cells by secreting death-inducing granules, such as granzymes/perforin, and modulating the Fas/FasL death receptor pathway [2,3]. The gene discussed is CD8A; the disease is neoplasm.